Relypsa, Inc.

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Completed	Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease Hyperkalemia, Resistant Hypertension	Phase 2	2017-01-23
Completed	Patiromer With or Without Food for the Treatment of Hyperkalemia Hyperkalemia	Phase 4	2016-02-01
Completed	A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of H Chronic Kidney Disease (CKD), Hyperkalemia (HK)	Phase 3	2013-02-01
Completed	Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN Chronic Kidney Disease, Hypertension, Hyperkalemia	Phase 2	2011-06-01
Completed	Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease Heart Failure	Phase 2	2010-05-01
Completed	Evaluation of Patiromer in Heart Failure Patients Hyperkalemia, Heart Failure	Phase 2	2009-04-01
Terminated	An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Part Hyperkalemia	Phase 2	2008-08-01